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Abstract
Background: Gammaretroviruses and gammaretroviral vectors, in contrast to lentiviruses and lentiviral vectors, are reported
to be restricted in their ability to infect growth-arrested cells. The block to this restriction has never been clearly defined.
The original assessment of the inability of gammaretroviruses and gammaretroviral vectors to infect growth-arrested cells
was carried out using established cell lines that had been growth-arrested by chemical means, and has been generalized to
neurons, which are post-mitotic. We re-examined the capability of gammaretroviruses and their derived vectors to
efficiently infect terminally differentiated neuroendocrine cells and primary cortical neurons, a target of both experimental
and therapeutic interest.
Methodology/Principal Findings: Using GFP expression as a marker for infection, we determined that both growth-arrested
(NGF-differentiated) rat pheochromocytoma cells (PC12 cells) and primary rat cortical neurons could be efficiently
transduced, and maintained long-term protein expression, after exposure to murine leukemia virus (MLV) and MLV-based
retroviral vectors. Terminally differentiated PC12 cells transduced with a gammaretroviral vector encoding the anti-
apoptotic protein Bcl-xL were protected from cell death induced by withdrawal of nerve growth factor (NGF),
demonstrating gammaretroviral vector-mediated delivery and expression of genes at levels sufficient for therapeutic effect
in non-dividing cells. Post-mitotic rat cortical neurons were also shown to be susceptible to transduction by murine
replication-competent gammaretroviruses and gammaretroviral vectors.
Conclusions/Significance: These findings suggest that the host range of gammaretroviruses includes post-mitotic and
other growth-arrested cells in mammals, and have implications for re-direction of gammaretroviral gene therapy to
neurological disease.
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Introduction
With the identification of a gammaretrovirus, xenotropic
murine leukemia virus-related virus, XMRV, as an emerging
human pathogen [1,2], and the use of gammaretroviral vectors in
gene therapy for human disease [3], examining the determinants
for host cell range of gammaretroviruses and gammaretroviral
vectors is of great public health significance. Growth-arrested cells
are reported to be susceptible to infection by lentiviruses and
lentiviral vectors but not gammaretroviruses [4,5] or gammare-
troviral vectors [6,7]. This has been attributed to the ability of
retroviruses of the lentiviral genus to cross an intact nuclear
membrane, owing to unique features of their preintegration
complexes ([8,9,10,11,12,13,14], also reviewed by Goff, and
Suzuki and Craigie [15,16]).
It has been proposed that lentiviral vectors have an advantage
over simple retroviral vectors in their ability to deliver genes to
nondividing cells because of unique genetic components intrinsic
to lentiviruses that allow the HIV pre-integration complex (PIC) to
cross the nuclear envelope in non-dividing cells. Third-generation
lentiviral vectors that retain the ability to infect neurons contain
only the HIV genes gag, pol, and rev, eliminating Vpr, Vpu and
Tat, as candidate factors essential for the transduction of neurons
and other non-dividing cells. The matrix component and other
gag proteins remain in third-generation lentiviral vectors. Matrix
was the first component implicated in nuclear import of HIV PICs
into the nucleus of non-dividing cells. Matrix was shown to contain
a short stretch of amino acid residues similar to nuclear
localization signals of cellular proteins, and to localize matrix-
fused cytosolic proteins to the nucleus [17,18]. However,
subsequent studies have not substantiated this role for matrix
[16]. Furthermore, matrix present in HIV particles does not
localize to the nucleus [19]. So far, no factors have been identified
that confer the ability of lentiviruses to infect non-dividing cells
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non-dividing human monocytes or macrophages to gammaretro-
viruses have suggested that they can be transduced at efficiencies
as high as 25% with Friend murine leukemia virus (F-MLV)-based
vectors harboring a rat VL30 packaging site [20]. On the other
hand, macrophages are said to harbor restrictive blocks to murine
leukemia virus (MLV) infection that can be overcome by
incorporating Vpx of HIV2/SIV into an MLV-based vector
[21]. Thus, it has so far not been possible to verify the hypothesis,
through transfer of discrete lentiviral elements to gammaretroviral
vectors, that unique and distinct lentiviral components confer the
ability to transduce post-mitotic cells.
The lack of consensus as to which retroviral components are
required for integration into post-mitotic cells caused us to embark
on a more detailed comparison of the structural requirements
underlying the presumed differential ability of gammaretroviruses
and retroviral vectors, compared to lentiviruses and lentiviral
vectors, to transduce, and integrate into the genomes of, post-
mitotic cells. In the process, we made the serendipitous discovery,
using viruses with a green fluorescent protein marker (GFP), that
infection of neurons, as well as growth arrested neuroendocrine
cells, occurs with murine leukemia replication-competent gam-
maretroviruses and MLV-based vectors at an efficiency similar to
that of lentiviral vectors, and sufficient to confer transgene
mediated phenotypes to cultured cells.
Results
Comparison of gammaretroviral and lentiviral vector
transduction of proliferating and differentiated PC12 cells
PC12 cells are a cell line derived from a rat pheochromocytoma
of the adrenal medulla [22] that extend neurites and undergo
growth arrest in the G1 phase of the cell cycle when treated with
nerve growth factor (NGF) [23,24,25]. We initiated our investi-
gation of differential gammaretroviral and lentiviral vector
transduction of non-dividing cells by comparing transduction of
PC12 cells by the gammaretroviral vector RT43.2GFP and the
lentiviral vector RRL-SIN-18 either before or after differentiation
with NGF. PC12 cells were exposed to vesicular stomatitis virus
(VSV)-enveloped MLV-based or HIV-based vectors (schematically
shown in Figure S1) produced in 293T cells and titered on murine
Mus dunni tail fibroblasts (MDTF cells) [26]. We used approxi-
mately 9.3610
5 infectious viral particles (as determined by
titration on a monolayer of MDTF cells) per chamber (each
containing 2.7610
4 cells as initially plated). This represents a
multiplicity of infection (MOI; virus particles per target cell) on the
PC12 cells of about 30. This MOI was chosen so that 100% of the
PC12 cells would be transduced, if transduction was as efficient as
in MDTF cells (i.e. PC12 cells were ,5% confluent at initiation of
exposure to virus, so that an MOI of 20 would be predicted to
transduce all cells). Transduction with both types of vector was
about equivalent both in proliferating (Figure 1, No NGF) and
differentiated (Figure 1, Plus NGF) cells and, based on the
calculated MOI and percent confluence, about 50% as efficient for
both types of vector particles as on MDTF cells. We speculate that
the slight loss in transduction efficiency for both lenti- and
gammaretroviral vectors in either undifferentiated or differentiated
PC12 cells, relative to MDTF cells, is attributable in part to the
culturing of PC12 cells in Matrigel, causing a partial barrier to
efficient vector-cell contact. In support of this, increasing MOI
substantially beyond 30 increased transduction efficiency to a
maximum of about 75% (Figure 2), suggesting that a proportion of
the cells are inaccessible to virus in the Matrigel configuration. We
also note here that green fluorescence following transduction with
Figure 1. Comparison of transduction efficacy between lentiviral and gammaretroviral vectors in proliferating and differentiated
PC12 cells. PC12 cells were grown in 4-well Matrigel-coated chamber slides and treated with 100 ng/ml NGF for 5 days before viral infection (Plus
NGF) or with vehicle alone for one day before viral infection (no NGF). Cells were exposed to an identical titer (9.3610
5 infectious lentiviral or
RT43.2GFP gammaretroviral particles/chamber). 7 days after infection, the cells were photographed at 106 with FITC filter (GFP-positive, virally
transduced cells) or phase contrast microscopy (all cells). Transduction efficiency was similar for both types of virus particle, and for both
undifferentiated and differentiated cells. Scale bar=20 mm.
doi:10.1371/journal.pone.0018072.g001
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within 2–3 days after transduction, consistent with viral integra-
tion, gene transcription, and translation of GFP mRNA, and
ruling out the possibility of pseudotransduction through GFP
expression via translation of unintegrated viral RNA [27].
Characteristics of gammaretrovirus/gammaretroviral
vector transduction of differentiated PC12 cells
Transduction of differentiated PC12 cells by the gammaretro-
viral vector at an efficiency comparable to that of lentiviral vectors
cannot be explained by transduction of a background of cells that
is still proliferating after 5 days of treatment with NGF. It has
previously been shown [28,29] and was subsequently confirmed by
us in the PC12 cell line used here (data not shown) that NGF
causes a progressive loss of BrdU incorporation from close to
100% in unsynchronized, proliferating cells to 0–20% after 5 days
of exposure to NGF. Thus, a background of proliferating cells
could not account for an equivalent efficiency of transduction at a
fixed viral input, as observed here (Figure 1). Retroviral vectors are
said not be amenable to transduction of cells in G1 phase because
it is during this time that the nuclear membrane is intact, and the
pre-integration complex cannot be formed in, or transported to,
the nucleus. We examined the possibility that although they are
growth arrested, PC12 cells are not completely arrested in a state
(G1) in which the nuclear membrane is intact. Recently, Hahn
et al. devised an indicator for growth arrest in G1 [30], consisting
in the C-terminus of the HDHB helicase, which is contained
exclusively in the nucleus in G1 and is exclusively cytoplasmic in
S1/G2, fused to tdimer2, an RFP ‘intramolecular’ red fluorescent
protein dimer developed by Campbell et al. [31]. We transferred
the expression cassette for this biological reporter into a LNCX
vector that provides expression of aminoglycoside phosphotrans-
ferase conferring resistance to the antibiotic G418. This construct
was packaged as described for RT43.2GFP, transduced into PC12
cells, and G418-resistant cells selected by growth in medium
containing 0.8 mg/ml G418. This cell line was used to analyze the
percentage of cells in G1 phase before and after treatment with
NGF for five days. As shown in Figure 3, most of the cells in the
culture (more than 98%) were in G1 phase after five days of NGF
treatment. Although proliferating cells also cycle through the G1
phase, the doubling time for PC12 cells (greater than 48 hours, see
Ravni et al., 2008 [32]) allows the conservative estimate that PC12
cells treated with NGF for five days offer no more than 5% of the
total population not in G1 phase over the period of time of viral
exposure and transduction. Thus, selective transduction of cells
not in G1 phase cannot explain the ability of gammaretroviral
vectors to transduce up to 80% of NGF-treated PC12 cells in
culture.
A second possible explanation for the ability of gammaretroviral
vectors to transduce G1-arrested PC12 cells and express protein
from the viral vector’s promoter is that the vector RNA genome
gains access to the cytoplasm, is reverse-transcribed, and that GFP
can in turn be transcribed from this proviral extranuclear gene.
Although this seems unlikely from a cell biological perspective, we
nevertheless isolated genomic DNA from transduced differentiated
PC12 cells and subjected this to PCR amplification to assay for
integrated vector DNA. Integrated viral DNA was found in
differentiated PC12 cells exposed to RT43.2GFP, with copy
number qualitatively similar to rat GAPDH, as judged by
comparison with GAPDH reference gene amplification (Figure 4).
Finally, we examined the persistence of GFP expression in
transduced differentiated PC12 cells (Figure 5). GFP expression
was maintained for up to one month in culture, consistent with
stable expression from an integrated viral promoter, since the
persistently strong GFP expression is seen well beyond both the
known half-life of GFP itself [33] and the ability of unintegrated
vector DNA to persist in transduced cells [34].
Gammaretroviral mediated gene delivery of Bcl-xL
rescues transduced PC12 cells from serum starvation-
and/or NGF withdrawal-induced death
Having demonstrated efficient transduction of differentiated
PC12 cells by MLV-based vectors bearing VSV envelope proteins
we proceeded to assess whether MLV-based vectors could deliver
and maintain expression of a transgene at levels sufficient to result
in therapeutic benefit. It has been previously shown that cell death
in PC12 cells can be induced by either serum or NGF withdrawal.
Furthermore, cell death induced in differentiated PC12 cells by
NGF withdrawal resembles that of NGF-deprived sympathetic
neurons [35]. Blomer et al. [36] used lentiviral vectors encoding
Bcl-xL, a protein that suppresses apoptotic cell death [37,38], to
assess whether death induced in differentiated PC12 cells by NGF
withdrawal could be prevented by exposure of these cells to
lentiviral vectors expressing Bcl-xL prior to NGF withdrawal.
Lentiviral vector mediated expression of Bcl-xL in PC12 cells
allowed cells to survive in the absence of serum or NGF [36]. We
adopted this experimental paradigm to assess whether we could
achieve similar results using gammaretroviral vector expressing
Bcl-xL. The vector we employed encodes a fusion protein
(GFPBcl-xL) previously shown to maintain wild type Bcl-xL
biological function [38]. Infection of PC12 cells with
RT43.2GFPBcL-xL vectors demonstrated the appropriate cyto-
plasmic redistribution of GFP expression to that associated with
GFPBcl-xL protein distribution in transduced cells (Figure S2) and
consistent with the previously reported distribution of Bcl-xL [38].
Figure 2. RT43.2GFP gammaretroviral vector transduction into
differentiated PC12 cells: effect of increased viral titer. After five
days of NGF treatment, differentiated PC12 cells grown on 4-well
chamber slides coated with Matrigel were exposed to concentrations of
viral particles ranging from 2.0610
5 to 2.0610
7 RT43.2GFP vector
particles in the presence of NGF. Three days after exposure to vectors,
cells were photographed with a 206 objective, using a FITC or DAPI
filter, after addition of DAPI. Transduction efficiency is expressed as the
mean of the percentage of DAPI-positive cells expressing GFP (ordinate)
from several fields for each transduction experiment, for different titers
of vector particles (abscissa).
doi:10.1371/journal.pone.0018072.g002
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RT43.2GFP or RT43.2GFPBcl-xL vectors and then assessed for
Bcl-xL-mediated survival effects after withdrawal of serum, in
order to examine the anti-apoptotic properties of Bcl-xL delivered
by gammaretroviral vectors. Seventy-two hours after PC12 cells
were exposed to gammaretroviral vectors, serum was withdrawn,
and cell death was assessed one and five days later. Expression of
gammaretroviral vector-delivered Bcl-xL significantly decreased
cell death induced by serum starvation after five days (Figure 6A,
bottom panels). Quantification of propidium iodide (PI)-stained
dead PC12 cells (Figure 6B) showed a statistically significant
difference in the PC12 cells exposed to RT43.2GFPBcl-xL (55%)
compared to those exposed to control vector (81%).
In order to insure that retroviral vector mediated Bcl-xL
expression was sufficient to rescue differentiated cells from cell
death, PC12 cells were exposed to either RT43.2GFP or
RT43.2GFPBclxL vectors, and treated with NGF for five days
after which NGF was withdrawn. Substantial rescue from cell
death after NGF withdrawal/serum starvation was observed at
day two in PC12 cells exposed to vectors expressing Bcl-xL,
compared to those exposed to control vector (Figure 7A). Two
days after NGF withdrawal 23% of the cells exposed to
RT43.2GFPBcl-xL were dead (PI stained) whereas 44% of cells
exposed to control RT43.2GFP vectors stained with PI (Figure 7B).
Three days after withdrawal, the effect was even more pro-
nounced, with 33% of the cells dead following exposure to
RT43.2GFPBcl-xL compared to 53% cell death for control cells
(Figure 7B).
Gammaretroviral mediated gene delivery of Bcl-xL to
differentiated PC12 cells provided rescue from NGF-
induced cell death
The experiments depicted in Figures 6 and 7 show that Bcl-xL
expression from a gammaretroviral transcriptional unit can protect
both proliferating and growth-arrested PC12 cells from cell death
triggered by serum or trophin withdrawal, but do not show that
the gammaretroviral transcriptional unit, when introduced into
post-mitotic cells, is capable of both efficient transduction and
functionally relevant expression. To demonstrate this, PC12 cells
were treated with NGF for five days prior to exposure to
Figure 3. Quantification of S/G2 cells in untreated and NGF-treated LNCX-HDHBc-tdimer2-transduced PC12 cells. LNCX-HDHBc-
tdimer2-transduced PC12 cells were plated into Matrigel-coated 4-well chamber slides, and left untreated for two days (No NGF; Figure 3A) or treated
with 100 ng/ml NGF for 5 days to allow full differentiation (Plus NGF; Figure 3B). Photodocumentation was at 206after staining with DAPI for nuclear
visualization by epifluorescence (blue), by phase contrast for cell visualization (black-and-white) or for nuclear or cytoplasmic HDHBc-tdimer2
visualization by epifluorescence (red). A. Arrows indicate an example of one cell (upper) in which fluorescence is excluded from the nucleus (S1
phase), and one (lower) in which fluorescence is restricted to the nucleus (G1 phase) in proliferating (No NGF) PC12 cells. Scale bar=10 mm. Panel at
lower right presents higher magnification of cells indicated by arrowheads immediately above. B. Arrows indicate two cells in which fluorescence is
restricted to the nucleus (G1 phase) in differentiated (Plus NGF) PC12 cells. Scale bar=10 mm. Panel at lower right presents higher magnification of
cells indicated by arrowheads immediately above. C. Percentage of cells with nuclear exclusion (versus sum of nuclear-excluded and nuclear-localized
cells) is plotted for No NGF and Plus NGF conditions.
doi:10.1371/journal.pone.0018072.g003
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subsequently maintained in NGF for an additional three days
prior to challenge with NGF withdrawal. PC12 cell complete
medium was then replaced with NGF- and serum-free medium.
Differentiated PC12 cells exposed to RT43.2GFPBcl-xL vectors
showed a significantly greater ability to survive at different days
after serum and NGF withdrawal (Figure 8). Thus,
RT43.2GFPBcl-xL transduction caused a significant decrease in
the percentage of dead cells resulting from serum starvation and
NGF withdrawal compared to control cells.
Gammaretroviruses and gammaretroviral vectors infect
rat cortical neurons
It was previously reported that cells must be mitotically active to
enable infection by gammaretrovirues such as MLVs [4,5]. These
experiments were carried out using NIH3T3 cells that had been
growth-arrested by serum withdrawal [4] or in rat fibroblast cell
lines that had been mitotically arrested by withdrawing serum and
adding aphidicolin [5]. Thus cortical neurons–post-mitotic
neuronal cells that cannot divide in culture–would be expected
to be resistant to infection by MLVs based on these previous
Figure 4. Detection of GFP-coding sequences within genomic DNA prepared from terminally differentiated PC12 cells transduced
with RT43.2GFP vectors. A. Representative gel picture showing genomic DNA fragment with size .10 Kb was used for PCR analysis.
Differentiated PC12 cells (5 days with NGF treatment) were exposed to RT43.2GFP vectors for 3 days, and then genomic DNA was isolated and run on
a 0.8% agarose gel to purify DNA fragment with size .10 Kb. (lane 2). Non-transduced PC12 cells were used as a negative control as represented by
lane 1. B. PCR analysis. The primer pair used for lane 1 (H2O), lane 2 (control PC12 genomic DNA) and lane 3 (differentiated gel purified transduced
PC12 genomic DNA) generated a GFP fragment of 636 bp in lane 3. Control primers specific for GAPDH were used for samples in lanes 5–7. Lanes 5 is
an H2O control, lane 6 contains DNA purified from control PC12 cells and lane 7 contains gel purified DNA from transduced differentiated PC12 cells;
lane 4 is an empty spacer lane.
doi:10.1371/journal.pone.0018072.g004
Figure 5. RT43.2GFP gammaretroviral vector transduction into differentiated PC12 cells: longevity of expression. PC12 cells were
grown in 4-well Matrigel-coated chamber slides, treated with NGF for 5 days, and exposed to gammaretroviral vectors in the continuous presence of
NGF. Representative examples of NGF-treated PC12 cells exposed to RT43.2GFP vectors were photographed with a 206objective, 3 days and 7 days
after exposure to viral vectors using phase contrast and a FITC filter. Representative fields of differentiated PC12 cells 9, 15, 21, and 29 days after
exposure to RT43.2GFP retroviral vectors were photographed using a FITC filter. Scale bars=20 mm.
doi:10.1371/journal.pone.0018072.g005
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were cultured in Neurobasal medium for seven days. Under these
conditions, proliferating cells such as astrocytes, microglia, and the
very small percentage of neuronal progenitor cells initially present
in embryonic day 18 cortical tissue are gone, and post-mitotic,
fully mature neuronal cells remain, with minimal (,1%)
contamination by glial cells [39,40]. Cultures were exposed to
AZE-GFP and confocal microscopy was used to identify infected
neurons. AZE-GFP (schematically depicted in Figure S1B) is an
infectious, replication competent form of Moloney MLV contain-
ing an amphotropic MLV envelope, and an internal ribosomal
entry site (IRES) adjacent to a GFP gene [41]. Five days after
initial exposure to AZE-GFP particles, primary cultures of rat
cortical neurons were stained with DAPI, a fluorescent stain that
binds DNA to monitor the number of cell nuclei in a microscopic
field, TuJ1 an antibody that detects neuron-specific class III b-
tubulin, and a GFP antibody that stains cells expressing the GFP
transgene. As shown in the merged image in Figure 9A, a
substantial number of TuJ1 positive cells in rat cortical neuronal
cultures were co-stained with GFP antibody (as shown by arrows).
Thus, replication-competent MLV can infect rat cortical neurons.
In addition to reports that growth-arrested cells were resistant to
infection by replication competent MLVs it has also been
previously shown that infectious but replication incompetent
MLV-based retroviral vectors also fail to infect chemically growth-
arrested cell lines [7,42]. Rat cortical neurons were exposed to
MLV RT43.2GFP vectors to obtain a quantitative assessment of
transduction. RT43.2GFP vectors, in contrast to AZE-GFP virus,
are not replication competent, therefore all GFP positive cells
represent ‘‘initial hit’’ target cells rather than cells infected as a
consequence of virus spread. A representative field of rat cortical
neurons five days after exposure to RT43.2GFP vectors is shown
in Figure 9B, left. Arrows depict TuJ1 positive cells that are also
GFP positive and therefore correspond to transduced neurons.
More than 50% of cortical neurons exposed to 8610
5 infectious
vector particles per well are transduced (Figure 9B, right). It is
important to note that the MOI used in our studies with retroviral
vectors was significantly lower (viral titer of 8610
5 shown in
Figure 6. RT43.2GFPBcl-xL vector exposure decreased PC12 cell death induced by serum withdrawal. A. Undifferentiated PC12 cells on
Matrigel-coated wells were transduced with control RT43.2GFP (left four panels) or RT43.2GFPBcl-xL vectors (right four panels) and then serum was
withdrawn for either one day (upper panels) or 5 days (lower panels). After either one or five days propidium iodide was used to stain dead cells, and
total cell count was obtained by Hoechst33342 staining. The cells were photographed with a 206objective using either a rhodamine (PI) or DAPI
filter. Scale bars=20 mm. B. Propidium iodide (PI) stained dead cells and Hoechst33342 stained total cells were used to determine the effects of
GFPBcl-xL expression (dark purple bar) compared to GFP expression alone (light purple bar) on cell viability. Percentage of PI positive cells versus
Hoechst33342 stained total cells is represented by the mean value of several fields obtained from three experiments. *P,0.01.
doi:10.1371/journal.pone.0018072.g006
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to show growth-arrested cell lines are resistant to MLV retroviral
vectors [7,42] and thus unlikely to represent pseudotransduction
i.e., the passive transfer of GFP. In fact, this gammaretroviral MOI
is lower than that used in typical lentiviral transductions (MOIs
around 20) in cultured rat cortical neurons reported by others
[40]. In addition, development of fluorescence in transduced
neurons, as in differentiated and undifferentiated PC12 cells, was
gradual over days, definitively ruling out the possibility of
pseudotransduction. Finally, we directly compared gammaretro-
viral and lentiviral vector transductions in cortical neurons. At an
MOI of 9, lentiviral transduction of cortical neurons was about
50% (Figure 10), similar to that seen for gammaretroviral
transduction of these cells.
Discussion
In this report, we demonstrate that gammaretroviruses, and
vectors derived from them, efficiently and stably transduce post-
mitotic neurons and neuroendocrine cells. Our results contrast
with a general consensus that gammaretorviruses are blocked from
stable integration into proliferation-arrested cells including post-
mitotic neural cells that possess an intact nuclear envelope
membrane. Stepwise optimization of virus and vector transduction
conditions in non-differentiated PC12 cells, differentiated PC12
cells, and finally in neurons, suggest that with all other factors
corrected for, differences in the structural features of gammare-
troviruses compared to lentiviruses are not themselves determina-
tive for efficiency of transduction of post-mitotic cells. Rather,
either type of virus can provide the minimal components necessary
for transduction of cells without disruption of nuclear envelope
integrity, i.e. in post-mitotic and/or growth-arrested cells.
Specifically, improvements in gammaretroviral vector develop-
ment have taken place since those initially used to conclude that
gene transfer by gammaretroviral vectors occurs only in cells that
are actively replicating at the time of transduction. These can be
summarized as follows. Employing quantifiable reporter genes,
such as GFP present in the AZE-GFP virus and RT43.2GFP
vector, replaces the requirement to detect viral protein expression
in productively infected cells [4,5] or the use of selectable markers
such as the G418
r gene employed in the previously reported
gammaretroviral vector studies [6,7]. The use of a GFP marker
precludes the need for G418 selection as well as providing a quick,
practical and sensitive means of quantifying transduced cells, via
direct observation. Similarly, infection of neurons by AZE-GFP
can be discerned by co-expression of GFP in concert with
appropriate phenotypic markers; thus, identification of infected
neurons in a mixed population of mitotically active and growth-
Figure 7. PC12 cells expressing Bcl-xL demonstrated reduced NGF-withdrawal induced death. A. Undifferentiated PC12 cells on
Matrigel-coated wells were transduced with control RT43.2GFP (left four panels) or RT43.2GFPBcl-xL vectors (right four panels), differentiated with
100 ng/ml NGF for five days, and then NGF was withdrawn for either 2 (upper panels) or 3 days (lower panels) after which PI was used to stain dead
cells and total cell count was obtained by Hoechst33342 staining. The cells were photographed with a 206objective using either a rhodamine or
DAPI filter. Scale bars=20 mm. B. PI stained dead cells and Hoechst33342 stained total cells were used to determine the effects of GFPBcl-xL
expression (dark purple) compared to GFP expression alone (light purple) on cell viability. Percentage of PI positive cells versus Hoechst 33342
stained total cells is represented by the mean value of several fields obtained from three experiments. *P,0.01.
doi:10.1371/journal.pone.0018072.g007
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of reverse transcriptase activity, or other viral infection detection
methods, but can be achieved using a GFP marker with reasonable
accuracy. Finally, the notion that gammaretorviruses and vectors
do not infect non-dividing cells originally grew from experiments
that demonstrated the inability of gammaretroviral vectors to
infect cell lines that were growth arrested by chemical means
[4,5,6,7]. PA317 MLV vectors used in these studies contain
amphotropic MLV (A-MLV) envelopes, which use the phosphate
transporter SLC20A2 as a receptor [43,44,45], and the previously
utilized replication competent ecotropic MLVs (E-MLV) use the
cationic amino acid transporter MCAT-1 as a receptor [46]. It is
worth considering the possibility that chemically induced growth
arrest may down-regulate SLC20A2 and MCAT-1 surface
proteins, resulting in an early block to A-MLV gammaretroviral
vector entry and E-MLV entry.
Thus, for a variety of historically valid, but since superseded,
methodological reasons, an appropriately rigorous scrutiny of the
ability of gammaretroviral vectors to transduce non-dividing cells
had not been previously undertaken since the initial reports
indicated lack of infectivity of non-dividing cells by gammare-
troviruses [6,7]. Similar considerations apply to the assessment of
the ability of gammaretroviral vectors to infect growth-arrested or
non-dividing neuron and neuroendocrine cells [36]. The ability of
gammaretroviruses to infect non-dividing cells has important
implications, as it suggests that the tropism of other gammare-
troviruses could be expanded to include cells previously thought to
be resistant to infection.
While vectors based on MLV currently offer no intrinsic
advantage over lentivirus-based vectors in transduction of post-
mitotic cells, our results clearly show that MLV-based vectors can
be employed to infect target cells previously considered to be
resistant to non-lentiviral retroviral vector mediated gene transfer.
We provide here evidence that gammaretroviral vector mediated
gene delivery to non-dividing cells occurs, and is efficient enough
to allow functional rescue of fully differentiated cells from
neurotrophin withdrawal-induced death by an anti-apoptotic
protein expressed from a retroviral vector. This suggests that
gammaretroviruses should be re-evaluated as functional gene
delivery tools for non-dividing cells. Proposals that gammaretro-
viral vectors encoding suicide genes be employed to selectively kill
dividing tumor cells in the nervous system may also require re-
evaluation of potential bystander effects on non-dividing cells [47].
Similarly, it may be appropriate to re-examine the assumption that
the quiescent status of hematopoietic stem cells is a major obstacle
to successful gammaretroviral vector mediated gene delivery to
these cells [48,49]. Finally, a broader range of cell types should
now be considered as potential targets for gammaretroviral
infection in the context of viral pathogenesis in diseases associated
with gammaretroviral infection, such as prostate cancer and
chronic fatigue syndrome [1,2].
Materials and Methods
Ethics statement
Experiments with cultured cortical neurons from rat brain (see
below) were carried out using protocols LCMR-14 and LCMR-15
for obtention of rodent tissue, which are current and fully
approved by the Animal Care and Use Committee of the National
Institute of Mental Health Intramural Research Program.
Plasmid construction
The RT43.2GFP or RT43.2GFPBcl-xL vector genome con-
tains two long terminal repeats (LTR), a CMV IE enhancer within
the U3 region of the LTR, MLV splice acceptor (SA) and donor
(SD) sequences, a packaging site and a GFP- or GFPBcl-xL-
encoding gene, schematically depicted in Figure S1A. The pAZE-
GFP plasmid is a biologically active clone obtained from the
laboratory of Christopher Logg [50]. It contains LTRs and gagpol
derived from Moloney murine leukemia virus and an envelope
gene derived from amphotropic MLV. Adjacent to the A-MLV
envelope is an IRES that permits expression of GFP, schematically
depicted in Figure S1B. The pRRL-SIN-18 plasmid was a
generous gift of Tom Dull (Cell Genesys, Foster City, CA) [51].
The G1 biosensor plasmid pHDHBc-tdimer2 was provided by
Dr. A.T. Hahn (Stanford University School of Medicine, Stanford,
CA).Tocreatethe HDHBc-tdimer2retroviralexpressionvectorthe
open reading frame consisting of the carboxy terminus of human
DNA helicase B fused to tdimer 2 [21] was isolated by digesting the
biosensor plasmid with EcoRI, filling in the 59 cleavage site
overhang with Klenow enzyme, and then digesting with HindIII.
This fragment was then ligated to the pLNCX retroviral plasmid
(Clontech, San Francisco, CA) previously digested with HindIII-
Hpa1. The resulting plasmid was sequence confirmed.
Production of AZE-GFP virus and LNCX-HDHBc-tdimer2
viral vectors, and production and titration of
gammaretroviral and lentiviral vectors
AZE-GFP virus and retroviral vector particles were produced
by transient transfection of 293T cells using Profection calcium
phosphate transfection kit (Promega, Madison, WI). For AZE-
GFP virus, 20 mg pAZE-GFP plasmid was transfected into 293T
cells and supernatants were pooled at 48 and 72 hours to produce
AZE-GFP virus that was subsequently combined, pre-cleared
through 0.45 mm syringe filters, and stored at 4uC. Particles were
then purified by ultracentrifugation through a 25% sucrose
cushion at 135,5006 g for 3 hours. The pellet containing
retroviral particles was resuspended in phosphate buffered saline
Figure 8. Differentiated PC12 cells exposed to RT43.2GFPBcl-
xL vectors are rendered less susceptible to death attributable
to NGF withdrawal. PC12 cells were plated on Matrigel-coated wells,
and treated with 100 ng/ml NGF for five days. Differentiated cells were
transduced with RT43.2GFP (grey) or RT43.2GFPBcl-xL (black) vectors
during continued treatment with NGF. Three days after infection, the
cells were washed with serum-free and NGF-free medium once and fed
with serum-free and NGF-free medium for different intervals. PI and
Hoechst33342 were added and the cells photographed using a 206
objective using either a rhodamine or DAPI filter. Percentage of PI
positive cells versus Hoechst33342 stained total cells is represented by
the mean value of several fields obtained from three experiments.
*P,0.001.
doi:10.1371/journal.pone.0018072.g008
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aliquots were stored at 280uC. For LNCX-HDHBc-tdimer2
vectors, 293T cells were transfected with 10 mg pLNCX-HDHBc-
tdimer2, together with 5 mg pVSV-G and 2.5 mg pMuLVgagpol.
48 hours after transfection, the supernatant was concentrated 16-
fold over Amicon 100,000 MW cut-off filters (Millipore, Billerica,
MA). Gammaretroviral vectors were produced by transient
transfection of 293T cells using a three-plasmid system: 10 mg
pRT43.2GFP or pRT43.2GFPBcl-xL plasmid, 2.5 mg MoMLV
gagpol plasmid, and 5 mg VSV-G envelope plasmid. Lentiviral
vectors were produced by transiently transfecting 293T cells with
three plasmids: 10 mg pRRL-SIN-18, 6.5 mg pMoMLVgagpol and
3.5 mg pVSV-G. After collecting viral supernatants, the vectors
were concentrated to a 500-fold stock as mentioned above. The
titer of concentrated vector particles was determined by transduc-
ing MDTF cells with serial dilutions of retroviral stock as follows:
MDTF cells were seeded at a density of 2.0610
4 cells per well in a
24-well plate and transduced 6 hours later. Sixteen hours after
transduction, medium was changed. GFP-positive cells were
counted 48 hours after transduction, and retroviral titer was
obtained by dividing the number of GFP-positive cells by the
volume of vector particles.
Figure 9. Rat cerebral cortical neurons are susceptible to infection by the gammaretrovirus, AZE-GFP, as well as RT43.2GFP
gammaretroviral vectors. A. Cortical neurons were cultured from rat embryo brains at day 18 for seven days in vitro and then exposed to AZE-GFP
in the presence of 1 mg/ml polybrene. Polybrene and virus were removed after 18 hours and cells immunostained with anti-GFP and TuJ1 antibodies,
followed by DAPI staining, five days post-AZE-GFP exposure, and photographed at 636with a laser scanning confocal microscope. Arrows indicate
GFP-positive TuJ1 positive cells. Scale bar=3 mm. B. Panel of representative confocal micrographs (left) of rat cerebral cortical neurons 5 days after
exposure to RT43.2GFP vectors. Cells were immunostained with anti-GFP antibody and TuJ1 antibodies, followed by DAPI staining. The lower right
hand quadrant of the panel shows the merged staining. Arrows indicate GFP positive, TuJ1 positive neurons. Scale bar=3 mm. Graph of transduction
efficiency (right) shows percentage of GFP-positive cells compared to total TuJ1 positive cells after exposure to 4610
4,1 610
5, and 8610
5 viral
particles.
doi:10.1371/journal.pone.0018072.g009
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Rat pheochromocytoma cells (the PC12 cell clone-derived line
PC12-G was used in these studies) [52] were cultured at 37uC
with 10% CO2 and grown in DMEM supplemented with 7%
fetal cow serum, 7% horse serum, 20 mM HEPES, and 1%
glutamate on Matrigel (BD Biosciences, San Jose, CA) coated 24-
well plates, or 4-well PermanoxH plastic chamber slides (Nunc,
Naperville, IL). Differentiated PC12 cells were obtained by
treating PC12 cells with 100 ng/ml 2.5S NGF (BD Biosciences)
after PC12 cells were plated, and fresh NGF was added every two
days.
Primary cultures of rat cortical neurons were prepared and
cultured as previously described [53]. Briefly, the cortical neurons
were obtained from dissociation of cerebral cortices from rat
embryos at day 18 by trypsinization and trituration, followed by
DNase treatment. The cortical neurons were then cultured on 8-
well Lab-Tek borosilicate coverglass chamber slides (Nunc) coated
with poly-D-lysine (Sigma-Aldrich, St Louis, MO), in 10% FBS for
one day followed by replacing medium with B27/Neurobasal
serum-free medium supplemented with 25 mM glutamate (Invi-
trogen, Carlsbad, CA).
Production of LNCX-HDHBc-tdimer2-transduced PC12
cells and quantification of cell cycle phase
PC12 cells were transduced with LNCX-HDHBc-tdimer2
retroviral vector, and selected with 800 mg/ml G418 for two
weeks. These cells were plated onto 4-well Permanox plastic
chamber slides coated with Matrigel, treated with 100 ng/ml
NGF for five days, fixed with 4% paraformaldehyde for
15 minutes, stained with 20 mg/ml DAPI, and photographed
with propidium iodide and DAPI filters at 206 magnification.
The untreated cells were also photographed in the same way.
The cells with red fluorescent nuclear localization (G1 cells) or
exclusion (S/G2 cells) were counted. The experiment was
repeated twice, and cells in 10–20 fields in each experiment
were counted.
Genomic DNA isolation and PCR analysis
PC12 cells were treated with NGF for 5 days to allow complete
differentiation, and then exposed to VSV-G-enveloped
RT43.2GFP vectors for 72 hours before being collected for
genomic DNA analysis. Genomic DNA was purified with the
Promega WizardH genomic DNA purification kit in accordance
with the manufacturer’s protocol. To eliminate any low molecular
weight DNA contamination, genomic DNA was run on 0.8%
agarose gel for 40 min, and DNA fragment with size .10 Kb was
excised and purified with the QIAEX II Gel Extraction Kit
(Qiagen, Valencia, CA). PCR analysis for the integrated GFP
sequences was performed using FastStart Taq DNA Polymerase
(Roche Applied Science, Indianapolis, IN). Approximately 75 ng
of each genomic DNA sample was used as template for PCR.
Primers for detection of the GFP band of 636 bp from provirus
were: 59-GGTGCCCATCCTGGTCGAGCTGGACG-39 (sense)
and 59-CGAACTCCAGCAGGACCATGTGATCG-39 (anti-
sense). As a control for DNA integrity, a 1 kb band was generated
with rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
primer pair: 59-GGTGAAGGTCGGTGTGAACGG-39 (sense)
and 59-CCAGGGTTTCTTACTCCTTGGAGGCC-39 (anti-
sense). The PCR program used to amplify genomic DNA started
with an initial activation step of 95uC for 5 minutes, followed by
30 amplification cycles of denaturing at 94uC for 30 seconds,
annealing at 65uC for 30 seconds, and extending at 72uC for
1 minute, and ended with a final extension at 72uC for 7 minutes.
PCR products were visualized with ethidium bromide after
electrophoresis in 0.8% agarose gel.
Assessment of the neuroprotective effects of Bcl-xL
delivered by gammaretroviral vectors in PC12 cells
PC12 cells were assessed for the ability of Bcl-xL to prevent
cell death using three different assay systems. First, undifferen-
tiated PC12 cells were exposed to retroviral particles and grown
in PC12 complete medium for three days, washed twice with
serum-free medium (DMEM medium, 20 mM HEPES and 1%
glutamate) and then cultured in serum-free medium. At different
intervals, the cells were stained with 1 mg/ml propidium iodide
(PI) (Calbiochem, San Diego, CA) to detect dead cells, and
5 mg/ml Hoechst33342 (Invitrogen) to detect total cells. The
randomly chosen fields were photographed at 206 using a
Nikon Eclipse Ti microscope equipped with black-and-white
CD camera, and the total and dead cells counted. Second,
undifferentiated PC12 cells were e x p o s e dt ov e c t o r sa n dt r e a t e d
with 100 ng/ml NGF for five days, and then underwent
simultaneous withdrawal of serum and NGF for different
periods of time, stained with PI and Hoechst33342, and
photographed at 206, after which the cells were counted. The
third method of assessment was performed with PC12 cells
being differentiated for five d a y si nt h ep r e s e n c eo fN G Fa n d
then exposed to viral vectors for three days in the continuous
presence of NGF, followed by withdrawal of NGF and serum.
At different day intervals after the withdrawal, the cells were
stained with Hoechst33342 and PI, and the numbers of total
and dead cells were assessed.
Figure 10. Transduction of lentiviral vectors into rat cerebral
cortical neurons. Cortical neurons were cultured from rat embryonic
brains at day 18 for seven days in vitro and then exposed to 9610
5
lentiviral vector particles, comparable to the highest MOI used for
gammaretroviral transduction. Five days later, the cells were fixed and
immunostained with anti-GFP and TuJ1 antibodies, followed by DAPI
staining. The cells were photographed with a laser scanning confocal
microscope at 636. Arrows indicate GFP-positive, TuJ1 positive cells.
Scale bars=3 mm.
doi:10.1371/journal.pone.0018072.g010
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cortical neurons after gammaretroviral infection
Five days after exposure to AZE-GFP virus in the presence of
1 mg/ml polybrene or to gammaretroviral vectors, cortical
neurons were fixed with 4% paraformaldehyde for 20 min, and
blocked with goat serum. The following primary antibodies were
used: AlexaFluor488-labeled rabbit polyclonal anti-GFP antibody
(Invitrogen) at 1:300 for GFP and monoclonal antibody TuJ1
(Covance, Berkeley, CA) at 1:300 for specific neuronal staining.
AlexaFluor594-labeled goat anti-mouse antibody (Invitrogen) at
1:200 was used as the secondary antibody. The nuclei of cells were
stained with 20 mg/ml DAPI. Confocal microscopy was used to
photograph the images of neurons in randomly chosen fields, and
the immunoreactive and total cells were counted.
Statistical analysis
Student’s two-tailed t-test was used for all statistical analysis.
Supporting Information
Figure S1 Schematic depiction of the replication-com-
petent GFP-expressing proviral genome and the pack-
ageable retroviral vectors employed in these studies. A.
RT43.2GFP or RT43.2GFPBcl-xL integrated genome containing
a packaging (Y) site that extends into gag coding region but lacks a
59ATG and with a TAG stop codon at the end of the optimized
packaging site. Genomes also contain genes encoding enhanced
GFP (RT43.2GFP) or GFP fused to Bcl-xL (RT43.2GFPBcl-xL).
B. AZE-GFP [50] is a biologically active MLV proviral genome
containing MLV LTRs and gagpol, and an amphotropic MLV
envelope gene. A gene encoding enhanced GFP driven by an
IRES is located downstream of the env gene. C. RRL-SIN-18, is a
self-inactivating lentiviral vector lacking the promoter region of
U3. Details of its construction are described in Dull et al., 1998
[51].
(TIF)
Figure S2 Intracellular distribution of GFP and GFP-
Bcl-xL proteins observed in PC12 cells transduced with
gammaretroviral vectors. PC12 cells transduced with con-
centrated viral vector particles containing either the RT43.2GFP
genome (A), or the RT43.2GFPBcl-xL genome (B). GFP is
distributed throughout the entire cell, whereas GFP fused to the
Bcl-xL protein is redistributed to cytoplasmic region consistent
with Bcl-xL protein distribution [38]. Fluorescent images were
taken on a Leica inverted microscope using iVision software at
206magnification. Calibration bar=50 mm. Enlarged inset areas
are outlined with red boxes.
(TIF)
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